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1. Introduction 
The transition from the G2 phase of the eukaryotic 
cell cycle to the mitotic phase produces dramatic 
morphological alterations, among which are the con- 
densation of chromatin to form chromosomes, and the 
disappearance of the nuclear membrane and nucleoli. 
These changes are accompanied by a nearly complete 
inhibition of cellular RNA synthesis [ 11. Recent work 
by Simmons et al. [2] indicates that inhibitors of 
protein synthesis did not prevent the resumption of 
RNA synthesis when mitotic cells entered the G1 
phase, suggesting that RNA polymerase is present but 
not active during mitosis. 
In recent studies on the regulation of polyoma 
virus transcription, we observed that an anionic deter- 
gent, Sarkosyl, caused a several-fold stimulation of 
endogenous RNA polymerase activity in mouse chro- 
matin [3] _ Nearly all of the increased activity was due 
‘to the c+amantin-sensitive RNA polymerase, [4-61, 
i.e., form II or B [7,4]. It was postulated that the 
Sarkosyl effect is due primarily to the release of one 
or more proteins which repress RNA polymerase II. 
Except for RNA polymerase, Sarkosyl caused the 
release of essentially all the proteins from chromatin 
(unpublished data). 
Based on these observations, it was questioned 
whether Sarkosyl could unmask the RNA polymerase 
activity from metaphase-arrested cells, in which the 
condensation of DNA is maximal. The experiments 
presented here provide evidence that RNA polyrnerase 
forms I and II remain associated with the chromo- 
somes of mouse cells undergoing mitosis. 
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2. Materials and methods 
Balb/C 3T3 cells were grown in Dulbecco’s 
modified Eagle’s medium supplemented with 10% calf 
serum. To arrest cells in metaphase, subconfluent 
cultures were treated for 19 hr with 0.4 Hg/ml. colcemid. 
The extent of mitosis was visually assayed by determin- 
ing the percentage of cells which were bright and round- 
ed by phase contrast microscopy. RNA synthesis was 
assayed by labeling cultures for 90 min with 
5’- [” H] uridine (16 Palo.2 pg/ml) and determining 
the amount of acid precipitable [“HI RNA, optical 
density at 260 nm, and DNA concentration [8] of 
separate aliquots. 
In vitro RNA polymerase assays were carried out 
as follows. Growing and colcemid-arrested cells were 
harvested by centrifugation and washed with Tris- 
buffered saline. The cells were resuspended in HR 
buffer (25 mM Tris-HCl, pH 7.9,0.S mM dithio- 
threitol, 1 .O mM MgClz , 0.4 mM CaClz ; ref. [9]), 
homogenized with a loose fitting Dounce homo- 
geniser, and adjusted to 0.09 M KCl, 0.2 M sucrose. 
Duplicate aliquots of the whole cell homogenates 
were treated with Sarkosyl (0.4%) plus Triton X- 100 
(0.1%) in TE buffer (0.01 M Tris-HCl, pH 7.9, 
0.2 mM EDTA). A modification of the reaction 
mixture of Roeder and Rutter [lo] was used in a 
final vol of 0.25 ml containing 56 mM Tris-HCl 
pH 7.9, 8 mM KCl, 6 mM NaF, 1.6 mM dithio- 
threitol, 46 mM ammonium sulfate, 1.8 mM MnClz , 
0.6 mM each of GTP, CTP, and ATP, 3 PM UTP, and 
0.6 PM [“HI UTP (2.2 MCi per assay). Polymerase 
reactions were carried out for the indicated periods 
of time at 22°C. 
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Reactions were stopped by the addition of 2 ml 
of ice-cold 0.1% trichloroacetic acid (TCA), followed 
by vigorous pipetting and an additional 1 ml of cold 
10% TCA containing 0.02 M pyrophosphate. After 
30 min on ice, the pretipitates were collected on 
Whatman GF/C filters, washed three times with cold 
5% TCA containing 0.01 M pyrophosphate and once 
with 95% ethanol, then dried and counted by liquid 
scintillation spectrometry. Assays with zero time 
incubation were used to determine background levels 
of incorporation; samples were left on ice and TCA 
was added immediately after addition of the radio- 
active reaction mixture. The backgrounds ranged 
from 100-300 cpm and have been subtracted from 
all data except those in table 3A. 
Native calf thymus DNA (grade A) was obtained 
from Calbiochem and where applicable, was denatured 
by boiling for 10 min. a-Amanitin was also purchased 
from Calbiochem. Rifamycin AF/O 13 was generously 
donated by Drs. Silvestri, Lancini and Cricchio of 
GruppoLepetit in Milan, Italy. 
3. Results and discussion 
Mouse 3T3 cells were arrested in metaphase by 
treatment with colcemid (0.4 pg/ml). Treated and 
control cultures were examined for the appearance 
of mitotic cells after 19 hr, and parallel plates were 
labeled for 90 min with [3H]uridine. In the experi- 
ment described in table 1, 80-90% of the colcemid- 
treated cells were observed to be in mitosis, and the 
incorporation of [ 3 H] uridine into RNA was reduced 
to 6% of that in growing cells. This result is in 
accordance with previously published data [ 11. 
Parallel unlabeled cultures of growing and colce- 
mid-treated cells were scraped off the plates and lysed 
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Fig. 1. Kinetics of RNA synthesis by Sarkosyl extracts of 
growing vs mitotic mouse cells. Growing and colcemid- 
arrested 3T3 cells were lysed by Sarkosyl treatment, then 
assayed for endogenous RNA polymerase activity as des- 
cribed in Materials and methods. Activities were normalized 
per input amounts of DNA, which was 10.2 pg from the 
colcemid-arrested cells and 12.2 pg from the control cells. 
by the addition of Sarkosyl. These extracts were 
used immediately to assay the kinetics of incorpora- 
tion of [“HI UTP into RNA. As seen in fig. 1, the 
Sarkosyl extract from mitotic cells had SO-85% of 
the RNA polymerase activity found in growing cells. 
The activities have been normalized to the amounts 
of RNA present, and are very close to the specific 
activity found by Sarkosyl addition to purified nuclei 
(unpublished data). In whole cell extracts of growing 
and metaphase-arrested cells prepared without 
Sarkosyl, the RNAgynthesized during the first 
10 min of the reaction was rapidly and completely 
Table 1 
RNA synthesis in growing vs mitotic mouse cells 
Mitotic [‘H]Uridine incorporated 
Conditions cells 
(%I CPM CPM/ODzo CPM/fig DNA 
No colcemid <5 98 488 24 622 1 244 (100%) 
Colcemid 80-90 5 616 2 447 76 ( 6.1%) 
Assays and conditions were as described in Materials and methods. 
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Table 2 
Effect of o-amanitin and Rifamycin Al;/01 3 on RNA 
polymerase activity in extracts of growing 
vs mitotic mouse cells 
state. Furthermore, there was no stimulation of 
endogenous activity by the addition of calf thymus 
DNA to the Sarkosyl extracts (data not shown). 
Additions 
[ 3 H]UMP incorporated 
No colcemid Plus colcemid 
(cpm) f%) (cpm) t%) 
None 11099 100 7266 100 
a-Amanitin: 1 crglml 2947 27 2140 30 
1 Oedml 2855 26 2121 29 
Rifamycin AF/013: 12 pg/ml 11 256 101 6942 96 
120 pg/ml 10 335 93 6918 95 
Aliquots of the same cell homogenates used in the experiment 
described in fig. 1 were preincubated with the indicated con- 
centrations of a-amanitin or Rifamycin AF/013 for 5 min at 
O”C, then assayed for endogenous RNA polymerase activity. 
Reactions were carried out for 60 min at 22°C. 
The strongest support for the above conclusion is 
provided by the differential effect of Sarkosyl on 
uninitiated as compared with initiated RNA poly- 
merase. DNA-dependent RNA polymerase was partially 
purified from HeLa cells as described by Kedinger 
et al. [ 131. In table 3A, it may be seen that 0.5% 
Sarkosyl, as well as Rifamycin AF/013, caused the 
nearly complete inactivation of uninitiated HeLa RNA 
polymerase. Little inhibition was caused by dimethyl- 
formamide (the solvent for Rifamycin) at a concentra- 
tion present in the Rifamycin analyses. 
hydrolyzed upon subsequent incubation (data not 
shown). Sarkosyl thus not only permits the efficient 
recovery of RNA polymerase activity from mitotic 
cells, but apparently is also a potent inhibitor of 
RNase in mouse cell extracts. 
It is possible that the small reduction of total 
activity in mitotic cell extracts was due to the 
specific loss of RNA polymerase I or III. The levels 
of both of these forms are thought to fluctuate 
markedly during the development of embryonic 
cells [6,11]. Using ol-amanitin to inhibit RNA 
polymerase II we found the same fraction (26-30%) 
of drug-resistant activity in the mitotic and growing 
cell extracts (table 2). Since the ol-amanitin resistant 
activity may be due to both RNA polymerase forms I 
and III [6], we cannot be certain that the ratio of 
forms I to III remained constant following colcemid 
arrest. However, it is clear that the small decrease in 
activity found in extracts from mitotic cells was not due 
to the preferential loss of RNA polymerase II. 
To examine the effect of Sarkosyl on initiated 
RNA polymerase, the activity was compared with that 
found when Rifamycin AF/O13 was added after 
starting the reaction (table 3B). Under the conditions 
described, approximately 65% of the initiated (i.e., 
rifamycin insensitive) polymerase activity was 
resistant to Sarkosyl with native calf thymus DNA as 
a template. With denatured DNA as a template, only 
about 25% of the initiated polymerase was resistant 
to Sarkosyl. In this experiment it was also found that 
with no inhibitors added, there was a 2.5fold increase 
in RNA synthesized between 60 and 2 10 min of the 
reaction with native DNA as a template (data not 
shown). With rifamycin or Sarkosyl present, the 
increase in newly synthesized RNA during that time 
interval was only 1.3-fold. This result indicates that 
Sarkosyl and Rifamycin AF/013 were equally active 
in blocking reinitiation by HeLa RNA polymerase. 
We thus conclude that RNA polymerase becomes 
resistant to Sarkosyl after initiating RNA synthesis on 
double-stranded DNA. Further studies are necessary 
in order to establish the precise step in transcription 
at which resistance occurs. Based on these and the 
above results we infer that there is nearly as much 
initiated RNA polymerase in mitotic cell chromo- 
somes as found in growing cells. 
We next addressed the question as to whether the The resistance of initiated RNA polymerase to 
Sarkosyl-activated RNA polymerase was localized on Sarkosyl NL-30 may seem surprising in that the 
the chromosomes in mitotic cells. As seen in table 2, structure of this anionic detergent (CH3(CH2)7CON- 
Rifamycin AF/OI 3 caused almost no inhibition over a (CHa)CH* COONa) superficially resembles that of 
IO-fold concentration range. Since this drug inhibits sodium dodecyl sulfate (SDS), which inactivates 
the known forms of uninitiated eukaryotic RNA initiated mouse RNA polymerase [3]. The similarity 
polymerase [ 121, it appears that the activity found in the action of Sarkosyl and Rifamycin AF/O13 may 
in mitotic cell extracts is present in an initiated be based on the 8 carbon hydrophobic chain common 
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Table 3 hydrophobic chain in SDS makes this detergent more 
A. Effect of Sarkosyl on uninitiated HeLa RNA polymerase 
activity 
readily accessible than Sarkosyl to RNA polymerase 
which has initiated synthesis on a native DNA tem- 
[‘H]UMP incorporated (cpm) 
plate. 
Further studies with purified chromosomes and 
No additions 18 898 chromatin are needed in order to understand how 
Dimethylformamide 16 230 
Rifamycin AF/O13 1 254 
RNA polymerase is repressed within these structures. 
Sarkosyl 459 
Since RNA polymerase appears to be in the initiated 
_ state on the chromosomes of mitotic cells, it is con- 
ceivable that nascent RNA chains as well as proteins 
B. Effect of Sarkosyl on initiated HeLa RNA polymerase play a role in making DNA unavailable for trans- 
activity cription. The Sarkosyl extraction method affords the 
Template Incubation [‘HJUMP Percent 
opportunity to study RNA polymerases which were 
conditions incorporated 
present in a repressed state during various stages of 
(cpm) viral or cell growth and development. 
Native Rifamycin, 60 min 855 100 
calf DNA Sarkosyl, 60 min 556 65 Acknowledgements 
Rifamycin, 210 min 1113 100 
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Denatured Rifamycin, 60 min 876 100 
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